Infliximab for chronic obstructive pulmonary disease: towards a more specific inflammation targeting?

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.15, Iss.2, 2006-02, pp. : 181-184

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting systemic inflammation: novel therapies for the treatment of chronic obstructive pulmonary disease

By Cazzola Mario Ciaprini Chiara Page Clive P Matera Maria G

Expert Opinion on Therapeutic Targets, Vol. 11, Iss. 10, 2007-10 ,pp. : 1273-1286

Informa Healthcare

Access to resources Recommend Favorite

Systemic inflammation and mortality in chronic obstructive pulmonary disease

By Sin Don D. Man S.F. P.

Canadian Journal of Physiology and Pharmacology, Vol. 85, Iss. 1, 2007-01 ,pp. : 141-147

NRC Research Press

Access to resources Recommend Favorite

Inflammation in Chronic Obstructive Pulmonary Disease: Implications for New Treatment Strategies

Current Medicinal Chemistry, Vol. 14, Iss. 7, 2007-03 ,pp. : 787-796

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting histone deacetylase 2 in chronic obstructive pulmonary disease treatment

By Barnes Peter J

Expert Opinion on Therapeutic Targets, Vol. 9, Iss. 6, 2005-12 ,pp. : 1111-1121

Informa Healthcare

Access to resources Recommend Favorite

Indacaterol: In Chronic Obstructive Pulmonary Disease

By Moen Marit D.

Drugs, Vol. 70, Iss. 17, 2010-12 ,pp. : 2269-2280

Adis International

Access to resources Recommend Favorite